BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23280838)

  • 21. [KCNE2 modulates the function of Kv4.3 channel].
    Liu J; Deng JX; Pan BX; Huang QB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1754-6. PubMed ID: 17259113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sodium channel accessory subunit Navβ1 regulates neuronal excitability through modulation of repolarizing voltage-gated K⁺ channels.
    Marionneau C; Carrasquillo Y; Norris AJ; Townsend RR; Isom LL; Link AJ; Nerbonne JM
    J Neurosci; 2012 Apr; 32(17):5716-27. PubMed ID: 22539834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene structures and expression profiles of three human KCND (Kv4) potassium channels mediating A-type currents I(TO) and I(SA).
    Isbrandt D; Leicher T; Waldschütz R; Zhu X; Luhmann U; Michel U; Sauter K; Pongs O
    Genomics; 2000 Mar; 64(2):144-54. PubMed ID: 10729221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.
    Spacey SD; Hildebrand ME; Materek LA; Bird TD; Snutch TP
    Ann Neurol; 2004 Aug; 56(2):213-20. PubMed ID: 15293273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.
    Boczek NJ; Ye D; Johnson EK; Wang W; Crotti L; Tester DJ; Dagradi F; Mizusawa Y; Torchio M; Alders M; Giudicessi JR; Wilde AA; Schwartz PJ; Nerbonne JM; Ackerman MJ
    Circ Res; 2014 Aug; 115(4):460-9. PubMed ID: 24963029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNE3 is an inhibitory subunit of the Kv4.3 potassium channel.
    Lundby A; Olesen SP
    Biochem Biophys Res Commun; 2006 Aug; 346(3):958-67. PubMed ID: 16782062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22.
    Li M; Liu F; Hao X; Fan Y; Li J; Hu Z; Shi J; Fan L; Zhang S; Ma D; Guo M; Xu Y; Shi C
    Front Mol Neurosci; 2022; 15():919199. PubMed ID: 35813061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Kv4.2 K+ currents by neuronal interleukin-16, a PDZ domain-containing protein expressed in the hippocampus and cerebellum.
    Fenster CP; Fenster SD; Leahy HP; Kurschner C; Blundon JA
    Brain Res; 2007 Aug; 1162():19-31. PubMed ID: 17618606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment.
    Delplanque J; Devos D; Huin V; Genet A; Sand O; Moreau C; Goizet C; Charles P; Anheim M; Monin ML; Buée L; Destée A; Grolez G; Delmaire C; Dujardin K; Dellacherie D; Brice A; Stevanin G; Strubi-Vuillaume I; Dürr A; Sablonnière B
    Brain; 2014 Oct; 137(Pt 10):2657-63. PubMed ID: 25070513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene.
    Koht J; Stevanin G; Durr A; Mundwiller E; Brice A; Tallaksen CM
    Acta Neurol Scand; 2012 Feb; 125(2):116-22. PubMed ID: 21434874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome.
    Frank-Hansen R; Larsen LA; Andersen P; Jespersgaard C; Christiansen M
    Clin Chim Acta; 2005 Jan; 351(1-2):95-100. PubMed ID: 15563876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of voltage-gated potassium channel 4.2 and voltage-gated potassium channel 4-interacting protein, and changes in intracellular calcium levels following lithium-pilocarpine-induced status epilepticus.
    Su T; Cong WD; Long YS; Luo AH; Sun WW; Deng WY; Liao WP
    Neuroscience; 2008 Dec; 157(3):566-76. PubMed ID: 18930118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interaction between KChIP1 and GFP-fused Kv4.3L co-expressed in HEK293 cells.
    Hatano N; Ohya S; Imaizumi Y
    Pflugers Arch; 2002 May; 444(1-2):80-8. PubMed ID: 11976919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures.
    Tokuda S; Kuramoto T; Tanaka K; Kaneko S; Takeuchi IK; Sasa M; Serikawa T
    Brain Res; 2007 Feb; 1133(1):168-77. PubMed ID: 17196942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathophysiology of neurodegenerative disease caused by γPKC mutations.
    Sakai N; Saito N; Seki T
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():95-8. PubMed ID: 21906004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residues within the myristoylation motif determine intracellular targeting of the neuronal Ca2+ sensor protein KChIP1 to post-ER transport vesicles and traffic of Kv4 K+ channels.
    O'Callaghan DW; Hasdemir B; Leighton M; Burgoyne RD
    J Cell Sci; 2003 Dec; 116(Pt 23):4833-45. PubMed ID: 14600268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
    Angelova PR; Müller WS
    Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New mutation of the Na channel in the severe form of potassium-aggravated myotonia.
    Kubota T; Kinoshita M; Sasaki R; Aoike F; Takahashi MP; Sakoda S; Hirose K
    Muscle Nerve; 2009 May; 39(5):666-73. PubMed ID: 19347921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco-Sjögren syndrome.
    Anttonen AK; Siintola E; Tranebjaerg L; Iwata NK; Bijlsma EK; Meguro H; Ichikawa Y; Goto J; Kopra O; Lehesjoki AE
    Eur J Hum Genet; 2008 Aug; 16(8):961-9. PubMed ID: 18285827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal A-type current and Kv4.2 channel modulation by the sulfonylurea compound NS5806.
    Witzel K; Fischer P; Bähring R
    Neuropharmacology; 2012 Dec; 63(8):1389-403. PubMed ID: 22964468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.